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Abstract
Background
Insufficient data exist on population-based trends in morbidity and mortality to determine
the success of prevention strategies and improvements in health care delivery in stroke.
The aim of this study was to determine trends in incidence and outcome (1-year mortality,
28-day case-fatality) in relation to management and risk factors for stroke in the multi-ethnic
population of Auckland, New Zealand (NZ) over 30-years.
Methods
Four stroke incidence population-based register studies were undertaken in adult residents
(aged15 years) of Auckland NZ in 1981–1982, 1991–1992, 2002–2003 and 2011–2012.
All used standard World Health Organization (WHO) diagnostic criteria and multiple over-
lapping sources of case-ascertainment for hospitalised and non-hospitalised, fatal and non-
fatal, new stroke events. Ethnicity was consistently self-identified into four major groups.
Crude and age-adjusted (WHO world population standard) annual incidence and mortality
with corresponding 95% confidence intervals (CI) were calculated per 100,000 people,
assuming a Poisson distribution.
Results
5400 new stroke patients were registered in four 12 month recruitment phases over the 30-
year study period; 79% were NZ/European, 6%Māori, 8% Pacific people, and 7% were of
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Asian or other origin. Overall stroke incidence and 1-year mortality decreased by 23% (95%
CI 5%-31%) and 62% (95% CI 36%-86%), respectively, from 1981 to 2012. Whilst stroke
incidence and mortality declined across all groups in NZ from 1991, Māori and Pacific
groups had the slowest rate of decline and continue to experience stroke at a significantly
younger age (mean ages 60 and 62 years, respectively) compared with NZ/Europeans
(mean age 75 years). There was also a decline in 28-day stroke case fatality (overall by
14%, 95% CI 11%-17%) across all ethnic groups from 1981 to 2012. However, there were
significant increases in the frequencies of pre-morbid hypertension, myocardial infarction,
and diabetes mellitus, but a reduction in frequency of current smoking among stroke
patients.
Conclusions
In this unique temporal series of studies spanning 30 years, stroke incidence, early case-
fatality and 1-year mortality have declined, but ethnic disparities in risk and outcome for
stroke persisted suggesting that primary stroke prevention remains crucial to reducing the
burden of this disease.
Introduction
The burden of stroke is large and increasing worldwide, with notable ethnic/racial disparities.
[1–7] Effective primary stroke prevention strategies are therefore critical in ageing populations
[1,8] and where there is increasing numbers of people surviving with stroke-related disability
and ongoing risk.[9] However, because of the considerable challenges to determining temporal
trends in incidence and outcome of stroke, there is limited information on the impact of
declines (or increases) in rates and case fatality in whole populations. This leaves uncertainties
regarding the impact of public health policies and improvements in health service delivery for
this important disease.[10–13]
As a large proportion of the burden of stroke is borne outside the hospital sector, it is crucial
that incident cases are ascertained and studied in a population-wide context.[10,11,13] Over the
last two decades new primary and secondary preventative strategies have been implemented but
the effect of the strategies on stroke burden have not been reliably assessed.[14] Accurate popu-
lation-based data on population trends in stroke incidence and risk factors reflect the success or
otherwise of prevention strategies, while case-fatality and mortality trends reflect management
and natural history of stroke. All these indices are crucial for evidence-based planning and
resource allocation for stroke services and preventive strategies. Yet population-based stroke
incidence studies are complex,[10,13] and are limited in number when compared to those using
hospital-based registers, mortality data, or studies limited to certain age groups. To address this
gap, we used population-based data from the four Auckland Regional Community Stroke
(ARCOS I—IV) studies (1981–1982, 1991–1992, 2002–2003 and 2011–2012) to determine
30-year trends in stroke incidence, case-fatality and mortality in the four major ethnic groups
(NZ European, Asian, Māori and Pacific Islanders) in Auckland, New Zealand (NZ).
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Materials and Methods
Study populations, case ascertainment and diagnostic criteria
The study population and methods of case ascertainment in the four ARCOS studies are
described in detail elsewhere.[12,15–18] In brief, these studies utilised harmonised population-
based registers of all new cases of stroke in the greater Auckland region over consistent 12
month calendar periods (total resident population aged15 grew from 596,580 in 1981–1982
to 1,119,192 in 2011–2012). Multiple overlapping methods of case ascertainment, and standard
WHO clinical diagnostic criteria for stroke were utilised.[19] For the 1991–1992 ARCOS
study, all hospital-managed stroke events in the region, and a cluster survey of 25% of all pri-
mary care general practitioners (GPs) records, were used to estimate the total number of non-
hospitalised, non-fatal stroke events.[12] For the 1981–1982 ARCOS study, a cluster sample of
50% of all registered GPs was used to identify a representative sample of stroke events in the
study population. All deceased cases were identified through hospital admissions and discharge
reports, systematic searches of post-mortem reports and death certificates in national registries.
Data for fatal non-hospitalised SAH cases were collected from medical records only. In the two
most recent studies (2002–2003 and 2011–2012)[12,15] no cluster sampling was used and
instead the whole study population was monitored for new stroke events. To ensure a complete
prospective case-ascertainment in 2002–2003 and 2011–2012 studies we undertook daily
searches of hospital presentation data, where a diagnosis suggesting stroke or transient ischae-
mic attack (TIA) was recorded for all public hospitals and emergency departments, CT/MRI
records and hospital discharge registers; weekly checks of all private hospitals, rest homes, and
community health services (general practices, hospital outpatient clinics and rehabilitation
centres); quarterly checks of coroner/autopsy records, death certificates (from Registrar of
Births, Deaths and Marriages) to identify people who had died with any mention of stroke, and
NZ Health Information Service data of all fatal and non-fatal stroke/TIA cases in the study
population. In 2002–2003 and 2011–2012 studies strokes were subdivided into pathological
types (ischaemic stroke [IS], primary intracerebral haemorrhage [PICH], subarachnoid haem-
orrhage [SAH]) according to neuroimaging (CT, MRI, or necropsy) findings. SAH was defined
as “an abrupt onset of a severe headache and/or impaired consciousness or focal neurological
signs associated with at least one of the following findings: uniform blood staining of the cere-
brospinal fluid; CT evidence of blood in the subarachnoid space; cerebral angiographic identifi-
cation of an aneurysm or arteriovenous malformation, or identification of SAH at surgery or at
autopsy. This definition excludes PICH with extension into the subarachnoid space and sub-
arachnoid bleeding due to trauma, neoplasms, or infections”.[20] All new stroke cases, includ-
ing suspected strokes, were ascertained by study researchers across all four studies. Consistent
diagnostic criteria were used across all studies to allow valid comparisons. Cases without imag-
ing or pathological necropsy confirmation of stroke type were classified as stroke of undeter-
mined type (undetermined). Cardiovascular risk factors and medication use were ascertained
via medical records across all studies. All study participants were followed up for 1 year for
fatal/non-fatal outcomes. Ethnicity was identified by self-report across all four studies.
Regional Ethics Committees approved all four studies.
Statistical analyses
For the 1981–1982 and 2002–2003 ARCOS studies participants selected one self-identified eth-
nicity to be used for the analyses. For the 1991–1992 and 2011–2012 ARCOS studies, multiple
self-identified ethnicities were recorded and ethnicity was prioritised corresponding to the allo-
cation process and using NZ census definitions for Māori, Pacific, Asian/other (“other”
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included ethnic groups such as other European, Middle Eastern, Latin American and African
ethnicities) and NZ Europeans as per the NZ Census.[21] When multiple ethnicities were self-
identified, ethnicity was prioritized as a single ethnic group for the purposes of analysis in the
following order: Māori, Pacific, Asian/other, NZ European. For example if a person self-identi-
fied as NZ European and Māori, they were classified as Māori, and if they self-identified as
Pacific and Chinese they were classified as Pacific. Ethnicity information was not available for
2 of the ARCOS 2011–2012 study participants and 46 of the ARCOS 2002–2003 study partici-
pants, who were excluded from the ethnicity analyses. Age, sex and ethnic structure of the cor-
responding Auckland census data were used as the denominator in calculating incidence.
Crude annual age-, sex-, and ethnic-specific stroke incidence (first-ever-in-a-lifetime
events) and attack rates (all events, including recurrent strokes), 28-day case fatality (propor-
tion [%] of people with stroke who died within 28 days of stroke onset among the total number
of people with incident stroke) and mortality rates (number of people with incident stroke who
died in the study population over one-year follow-up period [nominator] divided by the study
population at risk [denominator]), with 95% confidence intervals (CI) per 100,000 people were
calculated assuming a Poisson distribution. Sampling procedure differences between ARCOS
1981–1982 and 1991–1992 studies were taken into account when computing CI and standard
error (SE) of all estimated rates, as described elsewhere.[12] Standardised rates were calculated
using the direct method and age-standardised to WHO ‘World’ standard population.[22] Rate
ratios (RR) were calculated to evaluate differences in age-adjusted rates between the 1981–1982
and 2011–2012 study periods, and the Wald statistic test of heterogeneity across age groups
were performed.[12] For categorical variables, the Cochrane-Armitage test was used to assess
whether there was evidence of a statistically significant trend. For continuous variables, analysis
of variance or the Kruskal-Wallis test was used.
Completeness of case ascertainment based on the sources of notification was determined
using capture-recapture techniques.[23] This involved conducting log-linear modelling assum-
ing a Poisson distribution (unadjusted for sample procedures),[24] and used the four main
sources of notification: hospital, general practitioner, death certificate and other sources. The
final model with the least deviance, (deviance is an indicator of ‘goodness of fit’ and a lower
deviance suggests a better fitting model), for all studies included the main effects of the four
sources and the 3-way interaction between hospital, general practitioner and death certificate.
A Bonferroni-corrected threshold of p = 0.00013 (based on 380 tests conducted 0.05/380) was
used to indicate statistical significance after adjusting for multiple testing.
To compare our findings with similar population-based studies carried out in other coun-
tries we searched Medline with the terms”stroke”, “epidemiology”, “incidence”, “ethnic/racial”,
“trend(s)”, and “population or community based” for population-based studies of stroke car-
ried out between 1980 and 2014 and published in English. Only population-based studies from
high-income countries that reported age-specific raw numbers of first-ever-in-a-lifetime
strokes (numerator and populations at risk (denominator) sufficient to calculate incidence
rates age-standardised to WHO ‘World’ standard population[22] were included in the analysis.
We also compared trends in stroke incidence and mortality rates from our series of Auckland
Regional Community Stroke (ARCOS) studies (1981–1982, 1991–1992, 2002–2003, 2011–
2012) with those found in the Global Burden of Disease (GBD) 2010 study.[1,25]
Results and Discussion
Results
There were 5400 new stroke patients (47% men) registered across the four studies (Tables 1
and 2). Over the 30-year study period, the proportion of patients presenting with recurrent
Stroke Incidence and Outcomes Trends in a Multi-Ethnic Community
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Table 1. Baseline characteristics and 28-day outcome of stroke events in each ARCOS register.
1981–1982 1991–1992 2002–2003 2011–2012 P for trend§§
n (%) n (%) n (%) n (%)
Demographics
Male 662 (48.7) 817 (46.4) 892 (46.0) 1012 (48.3) 0.977
Age, mean (±SD), years***
NZ/European 72.2 (12.8) 73.5 (12.1) 75.6 (12.5) 75.3 (13.4) <0.0001§
Māori 56.7 (14.2) 55.0 (16.1) 60.7 (14.3) 59.6 (15.5) 0.04
Paciﬁc 55.8 (9.0) 59.7 (15.0) 64.5 (13.6) 61.6 (14.9) 0.002
Asian/other 72.1 (12.8) 65.6 (13.2) 65.9 (13.9) 67.5 (13.3) 0.199
Overall 71.2 (13.3) 71.6 (13.5) 73.0 (13.8) 71.6 (14.9) 0.001
Ethnicity
NZ/European 1248 (91.8) 1532 (87.0) 1431 (75.6) 1434 (68.5) <0.0001**§
Māori 60 (4.4) 82 (4.7) 102 (5.4) 138 (6.6)
Paciﬁc 32 (2.4) 111 (6.3) 197 (10.4) 270 (12.9)
Asian/other 20 (1.5) 36 (2.0) 162 (8.6) 252 (12.0)
Source of notiﬁcation <0.0001**§
Hospital 1082 (80.0) 1092 (62.0) 1361 (70.2) 1733 (82.7)
General practitioner 30 (2.2) 368 (20.9) 117 (6.0) 2 (0.1)
Death certiﬁcate 104 (7.7) 161 (9.1) 95 (4.9) 15 (0.7)
Other sources 136 (10.1) 140 (8.0) 365 (18.8) 346 (16.5)
Premorbid risk factors (from medical notes)
Current smoking
NZ/European 330 (26.7) 330 (21.7) 162 (12.6) 178 (12.8) <0.0001§
Māori 32 (53.3) 41 (50.6) 35 (38.9) 55 (40.4) 0.159
Paciﬁc 12 (37.5) 31 (28.7) 23 (13.1) 65 (24.4) 0.001
Asian/other 0 9 (25.0) 15 (10.3) 23 (9.3) 0.013
Overall 374 (27.7) 411 (23.5) 241 (14.0) 322 (15.8) <0.0001§
High blood pressure
NZ/European 632 (51.1) 802 (52.7) 783 (57.7) 947 (66.0) <0.0001§
Māori 38 (63.3) 41 (52.6) 63 (62.4) 85 (61.6) 0.690
Paciﬁc 22 (68.8) 49 (45.0) 124 (65.6) 178 (65.9) 0.022
Asian/other 8 (40.0) 18 (50.0) 88 (58.7) 184 (73.0) <0.0001§
Overall 700 (51.5) 910 (52.1) 1079 (59.0) 1394 (66.5) <0.0001§
Myocardial infarction
NZ/European 146 (11.8) 273 (17.9) 190 (13.5) 401 (28.0) <0.0001§
Māori 8 (13.8) 9 (11.4) 12 (11.9) 25 (18.1) 0.266
Paciﬁc 2 (6.7) 3 (2.8) 15 (7.9) 34 (12.6) 0.004
Asian/other 0 3 (8.3) 17 (11.0) 47 (18.7) 0.003
Overall 156 (11.5) 288 (16.5) 240 (12.7) 507 (24.2) <0.0001§
Previous stroke
NZ/European 314 (25.3) 404 (26.4) 361 (25.5) 308 (21.5) 0.015
Māori 14 (23.3) 21 (25.6) 12 (11.9) 21 (15.2) 0.041
Paciﬁc 2 (6.3) 25 (22.5) 54 (27.8) 62 (23.2) 0.234
Asian/other 0 6 (16.7) 36 (23.1) 56 (22.3) 0.067
Overall 330 (24.3) 456 (25.9) 477 (25.1) 448 (21.4) 0.016
Diabetes mellitus
NZ/European 98 (7.9) 193 (12.6) 179 (12.7) 236 (16.5) <0.0001§
Māori 20 (33.3) 19 (24.4) 35 (34.7) 41 (29.7) 0.975
(Continued)
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Table 1. (Continued)
1981–1982 1991–1992 2002–2003 2011–2012 P for trend§§
n (%) n (%) n (%) n (%)
Paciﬁc 12 (46.2) 16 (15.0) 69 (36.1) 117 (43.3) 0.0003
Asian/other 4 (20.0) 8 (22.2) 40 (26.1) 77 (30.6) 0.131
Overall 134 (10.0) 236 (13.6) 329 (17.4) 471 (22.5) <0.0001§
Atrial ﬁbrillation
NZ/European NA NA 328 (23.7) 460 (32.1) <0.0001§
Māori NA NA 29 (28.7) 42 (30.4) 0.774
Paciﬁc NA NA 41 (21.5) 62 (23.0) 0.704
Asian/other NA NA 18 (11.9) 47 (18.7) 0.075
Overall NA NA 416 (22.0) 611 (29.2) <0.0001§
Premorbid medication
Blood pressure lowering meds
NZ/European 428 (35.2) 539 (35.2) 712 (50.8) 910 (63.5) <0.0001§
Māori 26 (43.3) 21 (25.6) 49 (48.5) 79 (57.2) 0.001
Paciﬁc 16 (50.0) 30 (27.0) 94 (49.2) 168 (62.2) <0.0001§
Asian/other 6 (30.0) 14 (38.9) 73 (47.1) 163 (64.7) <0.0001§
Overall 476 (35.0) 604 (34.3) 942 (49.0) 1321 (63.0) <0.0001§
Antiplatelet agents
NZ/European 314 (27.4) 358 (23.4) 665 (48.2) 707 (49.3) <0.0001§
Māori 12 (21.4) 7 (8.5) 29 (29.6) 60 (43.5) <0.0001§
Paciﬁc 8 (28.6) 14 (12.6) 63 (33.5) 115 (42.6) <0.0001§
Asian/other 4 (25.0) 8 (22.2) 56 (36.6) 117 (46.4) 0.001
Overall 338 (24.8) 387 (22.0) 832 (42.9) 999 (47.7) <0.0001§
Anticoagulants
NZ/European NA 33 (2.2) 137 (9.9) 117 (8.2) <0.0001§
Māori NA 10 (12.2) 12 (12.2) 7 (5.1) 0.052
Paciﬁc NA 2 (1.8) 27 (14.1) 24 (8.9) 0.172
Asian/other NA 0 8 (5.2) 14 (5.6) 0.269
Overall NA 45 (2.6) 185 (9.9) 162 (7.7) <0.0001§
Lipid lowering drugs
NZ/European NA NA 213 (15.6) 567 (39.5) <0.0001§
Māori NA NA 13 (13.4) 58 (42.0) <0.0001§
Paciﬁc NA NA 19 (10.4) 117 (43.3) <0.0001§
Asian/other NA NA 27 (18.0) 116 (46.0) <0.0001§
Overall NA NA 272 (14.4) 858 (40.9) <0.0001§
Management
Admission to hospital within 28 days of stroke onset
NZ/European 768 (61.5) 1088 (71.0) 1283 (89.7) 1291 (90.0) <0.0001§
Māori 46 (76.7) 73 (89.0) 99 (97.1) 124 (89.9) 0.021
Paciﬁc 22 (68.8) 87 (78.4) 188 (95.4) 259 (95.9) <0.0001§
Asian/other 14 (70.0) 28 (77.8) 157 (96.9) 230 (91.3) 0.010
Overall 850 (62.5) 1276 (72.5) 1727 (91.3) 1904 (90.9) <0.0001§
Admission to acute stroke unit
NZ/European NA NA 140 (9.8) 709 (50.8) <0.0001§
Māori NA NA 32 (31.4) 61 (46.2) 0.021
Paciﬁc NA NA 39 (19.8) 140 (54.1) <0.0001§
Asian/other NA NA 24 (14.8) 131 (54.1) <0.0001§
(Continued)
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Table 1. (Continued)
1981–1982 1991–1992 2002–2003 2011–2012 P for trend§§
n (%) n (%) n (%) n (%)
Overall NA NA 238 (12.3) 1041 (51.3) <0.0001§
Neuroimaging, CT/MRI
NZ/European 134 (18.9) 429 (38.9) 1236 (86.4) 1389 (97.1) <0.0001§
Māori 18 (50.0) 50 (67.6) 99 (97.1) 134 (97.8) <0.0001§
Paciﬁc 6 (42.9) 50 (57.5) 180 (91.4) 261 (97.4) <0.0001§
Asian/other 4 (40.0) 12 (42.9) 153 (95.0) 244 (96.8) <0.0001±
Overall 162 (11.9) 541 (41.9) 1694 (87.6) 2030 (97.2) <0.0001§
28-day case-fatality
NZ/European 408 (32.7) 362 (23.6) 304 (21.2) 279 (19.5) <0.0001§
Māori 18 (30.0) 20 (24.4) 24 (23.5) 23 (16.7) 0.033
Paciﬁc 14 (43.8) 32 (28.8) 39 (19.8) 43 (15.9) <0.0001§
Asian/other 10 (50.0) 7 (19.4) 24 (14.8) 47 (18.7) 0.056
Overall 450 (33.1) 421 (23.9) 407 (20.7) 393 (18.8) <0.0001§
Pathological type of stroke
Ischaemic stroke NA NA 1380 (71.2) 1694 (80.8) <0.0001§
Primary intracerebral haemorrhage NA NA 236 (12.2) 275 (13.1) 0.368
Subarachnoid haemorrhage 90 (6.6) 76 (4.3) 96 (5.0) 87 (4.2) 0.008
Undetermined NA NA 226 (11.7) 40 (1.9) <0.0001§
Time from stroke onset to study assessment (days), median (interquartile range)*
NZ/European 19 (6–38) 17 (7–64) 27 (5–129) 6 (3–27) <0.0001§
Māori 31 (5–42) 18 (6–77) 25 (4–112) 7 (3–91) 0.097
Paciﬁc 21 (9–58) 13 (6–57) 15 (4–132) 5 (2–27) <0.0001§
Asian/other 29 (7–44) 12 (5–67) 18 (5–115) 6 (3–28) <0.0001§
Overall 20 (6–38) 16 (6–64) 27 (5–139) 6 (3–29) <0.0001§
Capture-recapture, missing**** 131/677 (19.3) 185/1449 (12.8) 144/1938 (7.4) 30/2096 (1.4) <0.0001§
§§P value calculated using Cochrane-Armitage trend test;
*P value calculated using Kruskal-Wallis test;
**P value calculated using Chi-squared test,
***P value calculated using analysis of variance test,
**** Using log-linear model containing main effects and interaction for hospital x general practitioner x death certiﬁcate. Information about medication was
collected in a month prior to stroke.
§ P-values that remained signiﬁcant after applying Bonferroni-correction to adjust for multiple testing for 380 tests (19 variables [age, source of notiﬁcation,
high blood pressure, myocardial infarction, previous stroke, diabetes mellitus, atrial ﬁbrillation, current smoking, blood pressure lowering medication,
antiplatelet agents, anticoagulants, lipid lowering drugs, admission to hospital within 28 days of stroke onset, admission to acute stroke unit,
neuroimaging/CT/MRI, 28-day case fatality, pathological type of stroke, time from stroke onset, capture-recapture) by 5 ethnic grouping (New Zealand
European, Maori, Paciﬁc, Asian/Other and Overall) by four points (ARCOS I 1981/1982, ARCOS II 1991/1992, ARCOS III 2002/2003, ARCOS IV 2011/
2012), giving a Bonferroni-corrected p-value threshold of = 0.05/380 tests = 0.00013
doi:10.1371/journal.pone.0134609.t001
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Table 2. Crude, age-specific and age-standardised annual stroke incidence rates (first-ever strokes) per 100,000 people-years in Auckland, New
Zealand across four study periods (1981–1982, 1991–1992, 2002–2003 and 2011–2012) by sex and ethnicity.
Age, sex and
ethnicity group
1981–1982 1991–1992 2002–2003 2011–2012 P for
N n Rate (95%
CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
trend
Total
15–64* 518112 286 55 (46; 64) 624828 347 56 (48;
63)
788106 391 50 (45;
55)
956037 528 55 (51;
60)
65–74 49812 260 522 (432;
612)
56388 373 661 (564;
759)
59454 336 565 (505;
626)
95190 363 381 (342;
421)
75–84 22965 350 1524
(1298;
1750)
31701 412 1300
(1139;
1460)
37815 438 1158
(1050;
1267)
48387 442 913 (828;
999)
85+ 5691 134 2355
(1791;
2918)
8541 173 2026
(1684;
2367)
12507 258 2063
(1811;
2315)
19578 310 1583
(1407;
1760)
Total 596580 1030 173 (158;
188)
721458 1305 181 (168;
194)
897882 1423 158 (150;
167)
1119192 1643 147 (140;
154)
<0.0001
Standardised§ 156 (143;
170)
156 (145;
167)
139 (132;
147)
119 (114;
125)
<0.0001
Male
15–64* 256500 164 64 (50; 78) 308997 197 64 (52;
75)
380139 216 57 (49;
64)
461418 264 57 (50;
64)
65–74 22251 158 710 (553;
867)
25452 201 790 (628;
951)
28173 198 703 (605;
801)
45678 211 462 (400;
524)
75–84 8742 150 1716
(1328;
2104)
11946 155 1298
(1038;
1557)
15210 189 1243
(1065;
1420)
21759 223 1025
(890;
1159)
85+ 1509 38 2518
(1386;
3651)
2421 34 1404
(932;
1876)
3633 64 1762
(1330;
2193)
6807 93 1366
(1089;
1644)
Total 289002 510 176 (155;
198)
348816 587 168 (150;
186)
427155 667 156 (144;
168)
535662 791 148 (137;
158)
0.0006
Standardised 184 (163;
209)
167 (150;
185)
156 (144;
168)
129 (120;
138)
<0.0001
Female
15–64* 261612 122 47 (35; 58) 315831 150 47 (38;
57)
407967 175 43 (37;
49)
494631 264 53 (47;
60)
65–74 27561 102 370 (269;
472)
30936 172 556 (437;
675)
31281 138 441 (368;
515)
49509 152 307 (258;
356)
75–84 14223 200 1406
(1131;
1682)
19755 257 1301
(1096;
1505)
22605 249 1102
(965;
1238)
26634 219 822 (713;
931)
85+ 4182 96 2296
(1646;
2945)
6120 139 2271
(1833;
2709)
8874 194 2186
(1879;
2494)
12771 217 1699
(1473;
1925)
Total 307578 520 169 (149;
190)
372642 718 193 (175;
211)
470727 756 161 (149;
172)
583545 852 146 (136;
156)
<0.0001
Standardised§ 133 (118;
151)
143 (130;
158)
124 (115;
133)
110 (103;
119)
<0.0001
European
15–64* 422202 224 53 (43; 63) 459267 233 51 (42;
59)
501426 222 44 (38;
50)
450759 252 56 (49;
63)
65–74 47481 238 501 (411;
591)
52125 341 654 (552;
756)
48633 219 450 (391;
510)
64806 239 369 (322;
416)
(Continued)
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Table 2. (Continued)
Age, sex and
ethnicity group
1981–1982 1991–1992 2002–2003 2011–2012 P for
N n Rate (95%
CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
trend
75–84 22209 342 1540
(1309;
1771)
30303 387 1277
(1114;
1441)
34332 378 1101
(990;
1212)
35916 354 986 (883;
1088)
85+ 5577 130 2331
(1764;
2898)
8253 167 2024
(1675;
2372)
11790 233 1976
(1722;
2230)
16776 279 1663
(1468;
1858)
Total 497469 934 188 (171;
205)
549948 1128 205 (189;
221)
596181 1052 176 (166;
187)
568257 1124 198 (186;
209)
0.992
Standardised§ 153 (139–
167)
150 (139;
163)
124 (116;
132)
122 (114;
130)
<0.0001
Māori
15–64* 52179 36 69 (37;
101)
63762 48 75 (49;
101)
77742 53 68 (50;
87)
88470 74 84 (65;
103)
65–74 1266 6 474 (-62;
1010)
1344 3 223 (-29;
476)
2292 22 960 (559;
1361)
4452 22 494 (288;
701)
75–84 336 4 1190
(-459;
2840)
429 8 1865
(573;
3157)
654 10 1529
(581;
2477)
1572 19 1209
(665;
1752)
85+ 51 0 0 72 2 2778
(-1072;
6628)
144 4 2778 (56;
5500)
243 2 823
(-318;
1964)
Total 53832 46 85 (51;
120)
65607 61 93 (65;
121)
80832 89 110 (87;
133)
94737 117 123 (101;
146)
0.014
Standardised§ 134 (78;
229)
168 (116;
241)
202 (157;
259)
156 (128;
189)
0.757
Paciﬁc
15–64* 33672 20 59 (23; 96) 64506 51 79 (55;
103)
89724 66 74 (56;
91)
107688 126 117 (97;
137)
65–74 741 10 1350 (167;
2532)
2025 21 1037
(481;
1593)
3840 47 1224
(874;
1574)
6417 43 670 (470;
870)
75–84 213 0 0 597 12 2010
(402;
3618)
1392 24 1724
(1034;
2414)
2679 29 1082
(689;
1476)
85+ 33 0 0 108 2 1852
(-715;
4418)
246 3 1220
(-160;
2600)
582 7 1203
(312;
2094)
Total 34659 30 87 (43;
130)
67236 86 128 (96;
160)
95202 140 147 (123;
171)
117366 205 175 (151;
199)
<0.0001
Standardised§ 147 (80;
269)
225 (163;
310)
218 (183;
261)
197 (171;
226)
0.374
Asian & Other
combined
15–64* 10059 6 60 (-8;
127)
37293 15 40 (13;
68)
119214 50 42 (30;
54)
309123 76 25 (19;
30)
65–74 324 6 1852
(-244;
3947)
894 8 895 (-86;
1875)
4689 42 896 (625;
1167)
19515 58 297 (221;
374)
75–84 207 4 1932
(-746;
4610)
372 5 1344
(166;
2522)
1437 21 1461
(836;
2086)
8220 40 487 (336;
637)
(Continued)
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strokes decreased by 2.95% (95% CI 0.60%-5.83%) from 24.3% to 21.4%. The mean age of indi-
viduals with stroke increased (on average by 3 years) across ethnic groups, except for Asian/
other ethnic group where age decreased by 4.6 years (95% CI 3.8–14.1). However, the 15-year
gap between in the mean age at stroke onset in Māori and Pacific (youngest age group) com-
pared with the mean age of stroke in NZ European (oldest age group) persisted over the 30
years. Although NZ European patients constituted the largest proportion of strokes, their pro-
portional frequency reduced by 23% (95% CI 21.0%-26.0%) over the same period, while the
proportional frequency of stroke patients from all other ethnic groups increased, with the larg-
est increase being 8-fold for the Asian/other ethnic groups (Table 1).
Between the 1981–1982 and 2011–2012 studies there were significant increases across all
ethnic groups in the proportion of patients admitted to hospital within 28 days of stroke onset
(28% [95% CI 26%-31%]), and in patients having neuroimaging verification of stroke patho-
logical types (84.9% [95% CI 62.8%-100.0%]). There were also increases in patients receiving
blood pressure lowering (27.0% [95% CI 24.0%-31.0%])) and antiplatelet (aspirin, clopidogrel,
dipyridamole: 21.0% [95% CI 17.0%-24.0%]) medications pre-stroke (Table 1). However, there
was a significant decrease in the proportion of stroke patients receiving anticoagulants pre-
stroke from 2002–2003 to 2011–2012 (2.1% [95% CI 0.66%-3.5%]).
We observed that risk factors prevalence increased significantly over 30 years (Table 1),
with the proportion of patients with a history of high blood pressure (160/95 mmHg; includ-
ing people on antihypertensive medication) increasing between the first and last survey by
15.0% (95% CI 11.7%-18.4%), myocardial infarction by 12.6% (95% CI 12.8%-15.1%), and dia-
betes mellitus by 12.5% (95% CI 10.1%-14.9%), across all ethnic groups except Māori for high
blood pressure, myocardial infarction and Type 2 diabetes mellitus, and Asian/other people for
diabetes mellitus. However, there was a statistically significant decrease in the frequency of cur-
rent smokers among stroke patients by 11.9% (95% CI 9.1%-14.8%), except for Pacific people
in whom the smoking rate over the last decade increased by almost two times. There was also a
noticeable reduction in the proportional frequency of strokes due to SAH (2.5% [95% CI 2.3%-
2.6%]), and a noticeable decline in 28-day stroke case-fatality of 14.8% [95% CI 9.7%-20.0%]
from 1981–1982 in 2011–2012 across all ethnic groups. Māori and Pacific people with stroke
had a greater prevalence of smoking (40.4% and 24.4%) and diabetes mellitus (29.7% and
43.3%) compared with NZ Europeans (12.8% and 16.5%, respectively), but lower prevalence of
MI (18.1% and 12.6% vs 28.0%) (Table 1).
Table 2. (Continued)
Age, sex and
ethnicity group
1981–1982 1991–1992 2002–2003 2011–2012 P for
N n Rate (95%
CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
trend
85+ 30 4 13333
(-5146;
31812)
108 2 1852
(-715;
4418)
327 7 2141
(555;
3727)
1971 22 1116
(650;
1583)
Total 10620 20 188 (72;
305)
38667 30 78 (40;
115)
125667 120 95 (78;
113)
338829 196 58 (50;
66)
<0.0001
Standardised§ 360 (185;
701)
158 (92;
271)
166 (137;
202)
68 (59;
79)
<0.0001
N is the estimated population size and n is the number of events.
* 16–64 in 2011–2012,
§ Age-standardised to WHO world population
doi:10.1371/journal.pone.0134609.t002
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Between 2002–2003 and 2011–2012, there were significant increases in the proportion of
stroke patients identified as having atrial fibrillation (AF) (7.2% [95% CI 2.4%-12.0%], only sig-
nificant for NZ Europeans), patients receiving lipid lowering medications (26.6% [15.0%-38.2%],
patients admitted to acute stroke unit (37.3% [95% CI 18.1–56.5%]). There was a significant
decrease of patients with undetermined stroke (from 11.7% to 1.9%), across all ethnic groups.
Age-standardised stroke mortality rates (Table 3) reduced by almost 3 times between 1981–
1982 and 2011–2012, declining from 98/100,000 (95% CI 88/100,000–110/100,000) person-
years in 1981–1982 to 37/100,000 (95% CI 34/100,000–40/100,000) person-years in 2011–2012
(test for trend p< 0.0001 [which remained significant after adjustment for multiple-testing]).
Decreases in age-adjusted 1-year stroke mortality rates were seen in NZ Europeans (2% per
year), Māori (1.4% per year) and Asian/other ethnic groups (7% per year) over the last 30
years. Age-adjusted stroke mortality rates (per 100,000 person-years) in Pacific people reduced
from 127 (95% CI 81–198) in 1991–1992 to 124 (95% CI 96–162) in 2002–2003 and 74 (95%
CI 58–95) in 2011–2012 (p for trend = 0.0002).
Over the 30-year study period, there was a 23% (95% CI 15%-31%) reduction in stroke inci-
dence (Fig 1) and 27% (95% CI 21%-33%) reduction in stroke attack rate overall (Table 4 and
Fig 1). These reductions were largely due to decreases in NZ Europeans (decrease 20% in inci-
dence, 26% attack rates) and Asian/others (decrease 81% [95% CI 63%-90%] in incidence, 75%
[95% CI 51%-87%] in attack rates) (Figs 2 and 3). However, in Māori and Pacific people, there
were non-significant increases in stroke incidence (first-ever strokes) and attack rates (incident
and recurrent strokes combined) between 1981–1982 and 2011–2012 study periods. Overall,
decreases in stroke incidence and attack rates were limited to people 65 years or older (Fig 3).
In people aged 15–64 years, there were no significant changes in stroke incidence or attack
rates, except for Pacific people where stroke incidence and attack rates doubled (Fig 1).
In 2011–2012, 54% (95% CI 48%-61%) of first ever incident and 51% (95% CI 46%-57%) of
recurrent strokes occurred in people younger than 75 years (Table 2). The proportion of inci-
dent and recurrent strokes in Māori and Pacific people younger than 75 years was twice that of
NZ Europeans (44% [95% CI 40%-48%] and 41% [95% CI 35%-47%] incident and recurrent
stroke in NZ Europeans aged 15–74 years compared to 82% [95% CI 74%-90%] and 80% [95%
CI 72%-89%] in Māori and 82% [95% CI 73%-93%] and 78% [95% CI 69%-89%] in Pacific
people aged 15–74 years, respectively). The temporal trends in declining stroke incidence and
attack rates were consistent in both males and females aged 65 years and older (Tables 2 and
4), with the most noticeable decline observed in males (Tables 2 and 4) and NZ Europeans
(Tables 2 and 4, Fig 1).
Stroke mortality rates increased with age across all study periods. In 2011–2012, there were
no significant differences in age-adjusted stroke mortality rates (per 100,000 person-years)
between males and females (39 [95% CI 35–44] and 35 [95% CI 32–40], respectively). In 2011–
2012, age-adjusted stroke mortality rates were highest in Pacific and Māori people (74 [95% CI
58–95] and 53 [95% CI 36–77], respectively), and lowest in Asian/other and NZ/European peo-
ple (27 [95% CI 21–34] and 35 [95% CI 31–39] respectively). Māori and Pacific people had a
test for trend of p<0.0001, which reflected both an increase in stroke incidence and mortality
rates from 1981–1992 and a decline in stroke incidence and mortality rates from 2002–2012.
All other ethnicities (NZ/Europeans, Asian/other), total, males, females all had test for trend
p<0.0001 which reflected the continuous decline in stroke incidence and mortality rates across
the study period. The overall current level of stroke incidence rates in NZ remains high com-
pared to other developed countries where comparable population-based stroke incidence stud-
ies were carried out in 2000–2014 period[26–32] (Fig 4).
Stroke Incidence and Outcomes Trends in a Multi-Ethnic Community
PLOS ONE | DOI:10.1371/journal.pone.0134609 August 20, 2015 11 / 28
Table 3. Crude, age-specific and age-standardised annual stroke mortality rates per 100,000 people in Auckland, New Zealand across four study
periods (1981–1982, 1991–1992, 2002–2003 and 2011–2012) by sex and ethnicity.
Age and ethnic
group
1981–1982 1991–1992 2002–2003 2011–2012 Trend
N n Rate (95%
CI)
N n Rate (95%
CI)
N n Rate (95%
CI)
N n Rate (95%
CI)
P value
Total
15–64* 518112 104 20 (15; 26) 624828 122 20 (16; 23) 788106 89 11 (9; 14) 956037 84 9 (7; 11)
65–74 49812 168 337 (265;
409)
56388 136 241 (196;
287)
59454 99 167 (134;
199)
95190 90 95 (75;
114)
75–84 22965 266 1158 (961;
1355)
31701 226 713 (615;
811)
37815 232 614 (535;
692)
48387 184 380 (325;
435)
85+ 5691 126 2214 (1667;
2761)
8541 148 1733 (1422;
2044)
12507 227 1815
(1579;
2051)
19578 237 1211
(1056;
1365)
Total 596580 664 111 (99;
123)
721458 632 88 (80; 95) 897882 647 72 (67; 78) 1119192 595 53 (49; 57) <0.0001
Standardise§ 98 (88; 110) 72 (67; 79) 57 (53; 62) 37 (34; 40) <0.0001
Male
15–64* 256500 58 23 (14; 31) 308997 61 20 (15; 25) 380139 48 13 (9; 16) 461418 36 8 (5; 10)
65–74 22251 98 440 (317;
564)
25452 83 326 (242;
410)
28173 59 209 (156;
263)
45678 55 120 (89;
152)
75–84 8742 100 1144 (827;
1461)
11946 102 854 (670;
1038)
15210 88 579 (458;
699)
21759 96 441 (353;
529)
85+ 1509 28 1856 (884;
2828)
2421 22 909 (529;
1288)
3633 58 1596
(1186;
2007)
6807 73 1072 (826;
1318)
Total 289002 284 98 (82; 114) 348816 268 77 (67; 87) 427155 253 59 (52; 67) 535662 260 49 (43; 54) <0.0001
Standardise§ 104 (88;
123)
76 (67; 87) 59 (52; 66) 39 (35; 44) <0.0001
Female
15–64* 261612 46 18 (10; 25) 315831 61 19 (14; 25) 407967 41 10 (7; 13) 494631 48 10 (7; 12)
65–74 27561 70 254 (170;
338)
30936 53 171 (125;
217)
31281 40 128 (88;
168)
49509 35 71 (47; 94)
75–84 14223 166 1187 (916;
1418)
19755 124 628 (517;
738)
22605 144 637 (533;
741)
26634 88 330 (261;
399)
85+ 4182 98 2343 (1687;
3000)
6120 126 2059 (1651;
2466)
8874 169 1904
(1617;
2192)
12771 164 1284
(1088;
1481)
Total 307578 380 124 (106;
141)
372642 364 98 (87; 108) 470727 394 84 (75; 92) 583545 335 57 (51; 64) <0.0001
Standardise§ 92 (79; 106) 67 (60; 75) 55 (50; 61) 35 (32; 40) <0.0001
NZ European
15–64* 422202 76 18 (12; 24) 459267 72 16 (12; 20) 501426 44 9 (6; 11) 450759 35 8 (5; 10)
65–74 47481 156 329 (256;
401)
52125 120 230 (183;
277)
48633 60 123 (92;
155)
64806 49 76 (54; 97)
75–84 22209 258 1162 (961;
1362)
30303 204 673 (578;
768)
34332 193 562 (483;
641)
35916 135 376 (312;
439)
85+ 5577 122 2188 (1639;
2737)
8253 145 1757 (1437;
2076)
11790 195 1654
(1422;
1886)
16776 204 1216
(1049;
1383)
Total 497469 612 123 (109;
137)
549948 541 98 (89; 107) 596181 492 83 (75; 90) 568257 423 74 (67; 82) <0.0001
Standardise§ 96 (86; 107) 67 (61; 74) 49 (45; 54) 35 (31; 39) <0.0001
Māori
(Continued)
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Discussion
The main findings of this study include: (a) a clear trend towards reducing stroke incidence,
28-day case-fatality and 1-year mortality rates; (b) an increase in the frequency of elevated
blood pressure, myocardial infarction, Type 2 diabetes mellitus and AF among stroke patients,
but decrease in the frequency of current smoking; (c) better survival of acute stroke patients
across all ethnic groups; and (d) persistent differences in stroke incidence, mortality rates and
risk factor prevalence across the four major ethnic groups in NZ. Overall, the ethnic disparities
have lessened overtime, especially over the last study decade. Our findings of decrease in stroke
Table 3. (Continued)
Age and ethnic
group
1981–1982 1991–1992 2002–2003 2011–2012 Trend
N n Rate (95%
CI)
N n Rate (95%
CI)
N n Rate (95%
CI)
N n Rate (95%
CI)
P value
15–64* 52179 14 27 (7; 47) 63762 18 28 (15; 41) 77742 16 21 (10; 31) 88470 17 19 (10; 28)
65–74 1266 6 474 (-62;
1010)
1344 3 223 (-29;
476)
2282 7 305 (79;
532)
4452 4 90 (2; 178)
75–84 336 4 1190 (-459;
2840)
429 9 2098 (727;
3469)
654 5 765 (94;
1435)
1572 9 573 (198;
947)
85+ 51 0 0 72 2 2778
(-1072;
6628)
144 2 1389
(-536;
3314)
243 3 1235
(-162;
2632)
Total 53832 24 45 (19; 70) 65607 32 49 (32; 66) 80832 30 37 (24; 50) 94737 33 35 (23; 47) 0.203
Standardise§ 96 (47; 196) 133 (85;
209)
77 (50;
118)
53 (36; 77) 0.015
Paciﬁc
15–64* 33672 12 36 (7; 64) 64506 27 42 (26; 58) 89724 17 19 (10; 28) 107688 22 20 (12; 29)
65–74 741 4 540 (-208;
1288)
2025 10 494 (188;
800)
3840 21 547 (313;
781)
6417 20 312 (175;
448)
75–84 213 0 0 597 10 1675 (135;
3215)
1392 19 1365 (751;
1979)
2679 16 597 (305;
890)
85+ 33 0 0 108 0 0 246 7 2846 (738;
4954)
582 10 1718 (653;
2783)
Total 33 16 46 (14; 78) 67236 47 70 (48; 92) 95202 64 67 (51; 84) 117366 68 58 (44; 72) 0.949
Standardise§ 69 (30; 160) 127 (81;
198)
124 (96;
162)
74 (58; 95) 0.005
Asian/other
15–64* 10059 2 20 (-19; 59) 37293 5 13 (2; 25) 119214 11 9 (4; 15) 309123 10 3 (1; 5)
65–74 324 2 617 (-593;
1827)
894 3 336 (-44;
715)
4689 8 171 (52;
289)
19515 16 82 (42;
122)
75–84 207 4 1932 (-746;
4610)
372 3 806 (-106;
1719)
1437 10 696 (265;
1127)
8220 24 292 (175;
409)
85+ 30 4 13333
(-5146;
31812)
108 1 926 (-889;
2741)
327 8 2446 (751;
4142)
1971 20 1015 (570;
1459)
Total 10620 12 113 (23;
203)
38667 12 31 (13; 49) 125667 37 29 (20; 39) 338829 70 21 (16; 25) <0.0001
Standardise§ 238 (102;
557)
70 (37;
132)
64 (45; 91) 27 (21; 34) <0.0001
* 16–64 in 2011–2012,
§ Age-standardised to WHO world population
doi:10.1371/journal.pone.0134609.t003
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incidence and mortality rates overall in the study population but an increase, although not sig-
nificant, in stroke rates in people younger than 64 years old (particularly females, Māori and
Pacific Island people) are concordant with those of the GBD 2010 Study which identified a con-
tinuous decline in stroke incidence and mortality rates in high-income countries,[1] and a
trend towards a stable or increasing stroke burden in people younger than 65 years.[1] The lat-
ter is of particular concern as our data showed an increased frequency of several major vascular
risk factors in people with stroke that was also observed in the general NZ population and
other countries.[14,33–35] This includes an epidemic of obesity and Type 2 diabetes mellitus
in children and young adults,[36,37] as well as behavioural and dietary risk factors.[38–40] An
increase (or no reduction) in the incidence of stroke in middle-age populations has been
observed in other studies,[41,42] thus re-emphasising the need for intensification of appropri-
ate primary stroke prevention strategies, especially on at a population level.
Although the overall decline in stroke incidence rates is in line with some population-based
studies,[43–47] the decline in stroke incidence in NZ over the last 30 years is almost 20% less
than that of comparable studies for a similar study period (Fig 4).[13,14,26–32,48–51] Further,
this study has highlighted that the relatively high level of stroke incidence in NZ is largely
attributed to high rates in Māori and Pacific people. Moreover, unlike similar studies,
[14,30,44] we found a significant trend towards increase in the prevalence of elevated blood
pressure, history of myocardial infarction and diabetes mellitus among stroke patients and this
Fig 1. Forest plot of stroke incidence and attack rate ratios (2011–2012 compared with 1981–1982), with rates age-adjusted to theWHOworld
population.
doi:10.1371/journal.pone.0134609.g001
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Table 4. Crude, age-specific and age-standardised annual attack (first-ever and recurrent strokes combined) rates per 100,000 people-years in
Auckland, New Zealand across four study periods (1981–1982, 1991–1992, 2002–2003 and 2011–2012) by sex and ethnicity.
Age, sex and
ethnicity group
1981–1982 1991–1992 2002–2003 2011–2012 P value
for trend
N n Rate (95%
CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
Total
15–64* 518112 350 68 (58;78) 624828 433 69 (61;
77)
788106 484 61 (56;
67)
956037 626 65 (60;
71)
65–74 49812 380 763 (654;
871)
56388 512 908 (795;
1021)
59454 460 774 (703;
844)
95190 476 500 (455;
545)
75–84 22965 498 2169
(1899;
2438)
31701 611 1927
(1730;
2125)
37815 667 1764
(1630;
1898)
48387 598 1236
(1137;
1335)
85+ 5691 178 3128
(2478;
3778)
8541 247 2892
(2460;
3324)
12507 390 3118
(2809;
3428)
19578 448 2288
(2076;
2500)
Total 596580 1406 236 (218;
253)
721458 1803 250 (235;
265)
897882 2001 223 (213;
233)
1119192 2148 192 (184;
200)
<0.0001
Standardised§ 211 (196;
228)
213 (201;
227)
193
(185;
202)
153
(147;
160)
<0.0001
Male
15–64* 256500 204 80 (64;
95)
308997 252 82 (69;
94)
380139 273 72 (63;
80)
461418 323 70 (62;
78)
65–74 22251 224 1007 (820;
1193)
25452 290 1139
(947;
1332)
28173 273 969 (854;
1084)
45678 272 595 (525;
666)
75–84 8742 216 2471
(2005;
2937)
11946 252 2109
(1768;
2451)
15210 277 1821
(1607;
2036)
21759 305 1402
(1244;
1559)
85+ 1509 46 3048
(1803;
4294)
2421 41 1694
(1175;
2212)
3633 95 2615
(2089;
3141)
6807 138 2027
(1689;
2366)
Total 289002 690 239 (214;
264)
348816 835 239 (218;
261)
427155 918 215 (201;
229)
535662 1038 194 (182;
206)
<0.0001
Standardised§ 248 (223;
276)
236 (216;
258)
214
(200;
228)
167
(157;
178)
<0.0001
Female
15–64* 261612 146 56 (43;
69)
315831 181 57 (47;
67)
407967 211 52 (45;
59)
494631 303 61 (54;
68)
65–74 27561 156 566 (440;
692)
30936 222 718 (587;
848)
31281 187 598 (512;
683)
49509 204 412 (356;
469)
75–84 14223 282 1983
(1655;
2310)
19755 359 1817
(1577;
2058)
22605 390 1725
(1554;
1897)
26634 293 1100
(974;
1226)
85+ 4182 132 3156
(2395;
3918)
6120 206 3366
(2799;
3934)
8874 295 3324
(2945;
3704)
12771 310 2427
(2157;
2698)
Total 307578 716 233 (209;
257)
372642 968 260 (239;
281)
470727 1083 230 (216;
244)
583545 1110 190 (179;
201)
<0.0001
Standardised§ 181 (163;
201)
190 (175;
206)
173
(162;
184)
140
(132;
149)
<0.0001
NZ European
(Continued)
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Table 4. (Continued)
Age, sex and
ethnicity group
1981–1982 1991–1992 2002–2003 2011–2012 P value
for trend
N n Rate (95%
CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
15–64* 422202 276 65 (54;
76)
459267 293 64 (55;
73)
501426 269 54 (47;
60)
450759 288 64 (57;
71)
65–74 47481 354 746 (636;
855)
52125 459 881 (764;
997)
48633 303 623 (553;
693)
64806 312 481 (428;
535)
75–84 22209 488 2197
(1922;
2473)
30303 579 1911
(1709;
2113)
34332 568 1654
(1518;
1790)
35916 470 1309
(1190;
1427)
85+ 5577 174 3120
(2464;
3776)
8253 241 2920
(2476;
3364)
11790 345 2926
(2617;
3235)
16776 400 2384
(2151;
2618)
Total 497469 1292 260 (240;
280)
549948 1572 286 (267;
305)
596181 1485 249 (236;
262)
568257 1470 259 (245;
272)
0.165
Standardised§ 209 (193;
226)
206 (193;
220)
171
(162;
180)
154
(145;
163)
<0.0001
Māori
15–64* 52179 46 88 (52;
124)
63762 58 91 (63;
119)
77742 60 77 (58;
97)
88470 88 99 (79;
120)
65–74 1266 10 790 (98;
1482)
1344 8 595 (183;
1008)
2282 24 1047
(628;
1466)
4452 25 562 (341;
782)
75–84 336 6 1786
(-235;
3806)
429 14 3263
(1554;
4973)
654 15 2294
(1133;
3454)
1572 24 1527
(916;
2138)
85+ 51 0 0 72 2 2778
(-1072;
6628)
144 5 3472
(429;
6516)
243 4 1646 (33;
3259)
Total 53832 62 115 (75;
156)
65607 104 129 (104;
153)
80832 104 129 (104;
153)
94737 141 149 (124;
173)
0.073
Standardised§ 192 (122;
304)
254 (188;
341)
247
(196;
311)
192
(161;
229)
0.867
Paciﬁc
15–64* 33672 22 65 (27;
104)
64506 65 101 (74;
127)
89724 88 98 (78;
119)
107688 155 144 (121;
167)
65–74 741 10 1350 (167;
2532)
2025 33 1630
(899;
2360)
3840 67 1745
(1327;
2163)
6417 64 997 (753;
1242)
75–84 213 0 0 597 13 2178
(536;
3819)
1392 39 2802
(1922;
3661)
2679 45 1680
(1189;
2171)
85+ 33 0 0 108 2 1852
(-715;
4418)
246 8 3252
(998;
5506)
582 15 2577
(1273;
3882)
Total 34659 32 92 (47;
138)
67236 113 168 (131;
205)
95202 202 212 (183;
241)
117366 279 238 (210;
266)
<0.0001
Standardised§ 152 (85;
274)
291 (220;
384)
329
(284;
382)
275
(244;
310)
0.012
Asian/other
15–64* 10059 6 60 (-8;
127)
37293 17 46 (17;
74)
119214 64 54 (41;
67)
309123 95 31 (25;
37)
(Continued)
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may be a contributing factor to the observed differences in NZ compared to other high-income
countries. Indeed, the 2008/2009 NZ Adult Nutrition Survey showed that there was an increase
in mean systolic blood pressure in the overall population since 2002, but in particular in Māori
men aged 35–74. The prevalence of hypertension in the NZ population in 2008/2009 was esti-
mated at 31%, with only 15% on anti-hypertensive medication.[39] However, the increasing
prevalence of elevated blood pressure, MI and Type 2 diabetes in stroke patients may also be
related to increased detection of undiagnosed hypertension, diabetes and other health condi-
tions over the study period, therefore these data should be interpreted with caution. The pro-
portion of recurrent strokes has shown a statistically significant decrease over the study period
overall and NZ European and Maori people in particularly, although the level of recurrent
strokes (21.4%) in NZ remains relatively high compared to some other developed countries.
[52] There was no statistically significantly change in the proportion of recurrent strokes in
Pacific, Asian and other ethnic groups in NZ from 1981 to 2012 and but showed a trend
towards increasing. This and the overall high rate of recurrent strokes in NZ (especially in
Maori and Pacific people younger than 75 years) signify the need for better, culturally appro-
priate secondary stroke prevention strategies.
The younger age of stroke onset in Māori is also reflected in the lower life expectancy at
birth of Māori, which in 2006 was at least eight years less than that for non-Māori for both
genders.[53] Of note is the increase in the prevalence of atrial fibrillation and low levels of pre-
morbid anticoagulation of patients with AF over the last decade. Despite 36.1% of ischaemic
stroke patients having AF in the 2011–2012 study, only 26.5% of these patients were being
treated with anticoagulation therapy prior to stroke. A similar increase in the prevalence of AF
in stroke patients was recently observed in another population-based study.[54] This, together
with the global epidemic of AF,[55] suggests that it is now becoming the leading risk factor for
stroke.
Similar diverging trends and ethnic disparities in stroke incidence have been shown in other
comparable population-based studies in the US[43] and UK,[44] suggesting unfavorable trends
in the prevalence of risk factors.[56] In the Atherosclerosis Risk in Communities cohort there
Table 4. (Continued)
Age, sex and
ethnicity group
1981–1982 1991–1992 2002–2003 2011–2012 P value
for trend
N n Rate (95%
CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
N n Rate
(95% CI)
65–74 324 6 1852
(-244;
3947)
894 12 1342
(268;
2416)
4689 55 1173
(863;
1483)
19515 74 379 (293;
466)
75–84 207 4 1932
(-746;
4610)
372 5 1344
(166;
2522)
1437 34 2366
(406;
3161)
8220 58 706 (524;
887)
85+ 30 4 13333
(-5146;
31812)
108 2 1852
(-715;
4418)
327 10 3058
(1163;
4954)
1971 29 1471
(936;
2007)
Total 10620 20 188 (72;
305)
38667 36 93 (54;
132)
125667 163 130 (110;
150)
338829 256 76 (66;
85)
<0.0001
Standardised§ 360 (185;
701)
194 (122;
310)
234
(197;
277)
90 (79;
101)
<0.0001
* 16–64 in 2011–2012,
§ Age-standardised to WHO world population
doi:10.1371/journal.pone.0134609.t004
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was a 40% increase in the proportion of hypertension and diabetes from 1987 to 2011.[46] Eth-
nic differences in stroke risk have been attributed to differences in socioeconomic status (SES)
and exposure to risk factors.[57] Lower SES groups have greater exposure to cardiovascular
risk factors, including hypertension, smoking, poor diet, physical inactivity, diabetes and excess
alcohol use.[58] Also, lower SES groups may have limited access to, or make less effective use
of, services to manage these risk factors (e.g., early hypertension detection and control).[59]
However, there is evidence that not all differences among ethnic groups are explained by differ-
ences in cardiovascular risk factors, suggesting genetic[60] and other factors such as socioeco-
nomic disparities and the experience of discrimination[61] may be important. There remains
uncertainty about the relative importance of stroke risk factor management and other factors
in causing these inequalities. The impact of SES, changing family dynamics and cultural values
on stroke risk and recovery in Māori and Pacific Island people is uncertain.[62] Ethnic-specific
differences in stroke risk factors have also been shown in some other multi-ethnic populations
[63–70] suggesting the need for culturally tailored primary and secondary preventative
strategies.
Fig 2. Stroke incidence rates over 3 decades by ethnicity.
doi:10.1371/journal.pone.0134609.g002
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If the current temporal trend in the distribution of stroke risk factors in the population con-
tinues, we are likely to observe an increase in the incidence of stroke in the near future. Primary
stroke prevention is a mainstream strategy to reduce stroke burden in a population.[71–73]
However, the relative significance of various determinants of stroke occurrence as well as cul-
tural appropriateness of stroke prevention strategies, especially among Māori and Pacific peo-
ple,[3] are not known, hindering the development of effective, evidence-based primary stroke
prevention strategies on both individual and population levels.[4,74–79] Furthermore, a
detailed analysis of recent changes in stroke risk factors is needed to explain the diverging
trends in stroke incidence and mortality rates in the different ethnic groups in NZ and to fur-
ther inform culturally appropriate primary stroke prevention strategies.[80]
Better management (including enhanced admission rates to acute stroke units) and result-
ing improved 28-day and 1-year survival of acute stroke patients have been observed in other
studies.[13,32,81,82] Although hospital admission has improved in this study over the 30 year
period, there is still an underutilisation of acute stroke units (only 51% of stroke patients were
treated in acute stroke units) and thrombolytic therapy for ischaemic stroke patients (only 5%
of ischaemic stroke patients received alteplase [data not shown]) against the recommended
Fig 3. Stroke incidence rates over 3 decades by 4 age groups.
doi:10.1371/journal.pone.0134609.g003
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corresponding figures in the NZ guidelines.[83] A recent individual-participant data meta-
analysis of alteplase[84] demonstrated that irrespective of age or stroke severity, and despite an
increased risk of fatal intracranial haemorrhage during the first few days after treatment, alte-
plase significantly improves the overall odds of a good stroke outcome when delivered within
45 h of stroke onset, with earlier treatment associated with bigger proportional benefits. Simi-
lar to some previous observations[85,86] but contrary to others[87–89] we found a moderate,
though non-statistically significant, decrease in the incidence of subarachnoid haemorrhage
that may be related to the reduced smoking rates[90] in NZ.[91]
The observed level and magnitude in stroke mortality decline in Auckland, NZ (3-fold
decline [from 98/100,000 person-years in 1981–1982 to 37/100,000 person-years in 2011–
2012]) is similar to official NZ statistics on stroke mortality rates,[92] supporting the validity of
our data. However, our findings of faster declines in stroke mortality rates than stroke inci-
dence rates, in line with our previous estimates,[93] suggest a further rise of stroke related dis-
ability over the next decade due to population growth and aging in NZ. This is of particular
importance for Māori and Pacific groups where there has been a substantial increase in stroke
in younger age groups, thus emphasizing the importance and priority of primary stroke pre-
vention. A mismatch in temporal trends between stroke incidence and mortality rates has been
shown in some other populations.[94]
Novelty and Translation
To the best of our knowledge, this is the first, longest and largest population-based survey to
compare long-term trends and 1-year outcomes of stroke. There are several important new
findings reported in this paper. The first is the diverging and changing trends in stroke inci-
dence and stroke risk factors in different ethnic groups of the population. The trends in stroke
Fig 4. Annual age-adjusted stroke incidence rates in population-based studies[14,26–32,48–51] carried out in high-income countries in 2000–
2014.
doi:10.1371/journal.pone.0134609.g004
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incidence for Māori and Pacific Island people behave are similar to those observed in low to
middle-income countries, while in NZ/ Europeans, trends in stroke incidence are like those in
high-income countries with ethnically more homogeneous populations. Ethnicity/race is a
proxy for disparity[95] and this is relevant internationally because other ethnically diverse soci-
eties will need to make provisions for population sub-groups prone to disparity to ensure that
they have access to appropriate health care. Second, our findings were obtained before and dur-
ing contemporary changes in prevention (primary and secondary) and service delivery (acute
stroke unit care and thrombolysis) in a whole population context. This provides, for the first
time, direct feedback to health-policy decision-makers on the relative success of these changes
in medical practice. Specifically, the study demonstrated that current stroke preventative and
management strategies are far more effective in reducing stroke risk and mortality on a popula-
tion level than those used before mid-1990s. This should encourage health systems worldwide
to seriously consider implementing modern stroke preventive and treatment strategies if they
have not already done so. Third, this is the first documentation, to the best of our knowledge,
of stroke mortality rates falling faster than stroke incidence rates. If this trend is also borne out
in other populations then health systems will need to adapt in order to accommodate the likely
increase in rehabilitation services needs in order to cater for this increase in prevalence and,
therefore, make plans to implement more effective and culturally appropriate primary stroke
prevention strategies at a population level. The differences in the stroke incidence trends by
ethnicity are also important to take into account when projecting stroke burden in multi-ethnic
communities on a national and global scale (including Global Burden of Disease estimates)
and further reinforce the need for culturally appropriate prevention and health care strategies
in multi-ethnic communities. The diverging trends in stroke incidence in the different ethnic
groups and different rates of reduction in stroke mortality and incidence rates should be gener-
alizable to other ethnically diverse health-care systems that have achieved similar risk factor
modification.
Strength and limitations
The strength of our study is that it includes four large prospective population-based stroke reg-
isters (5400 stroke patients; 3,335,112 person-years of observation) across a long timespan
(over 30 years: 1981–2012). The major limitation of the study was a relatively low number of
strokes in some ethnic groups, especially in the Asian/other ethnic group making it difficult to
determine whether trends in incidence, attack and mortality rates were statistically significant.
Although the numbers were small, one possible explanation for the apparent large reduction in
stroke incidence and mortality rates in Asian/other ethnic group may be related to the large
influx of younger, presumably generally healthy, Asian immigrants in NZ that has been partic-
ularly marked over the last two decades.[21] The NZ Health and Disability sector uses the NZ
Health Statistics definition for ethnicity ‘as a social construct of group affiliation and identity’
where ‘‘ethnicity is the ethnic group or groups that people identify with or feel they belong to’.
[96] In the 1981–1982 and 2002–2003 studies, only one ethnicity was collected for participants
in each study, preventing us from applying prioritised ethnicity classification in these studies.
Although this may have introduced a classification bias by ethnicity, we believe the effect of the
bias was not large and was likely to be non-differential as most of the ethnic priority classifica-
tions in the 1991–1992 and 2011–2012 studies were also based on the first ethnicity self-identi-
fied by the study participants. In addition, less than 10% of the last surveys study participants
indicated more than one ethnicity. We lacked statistical power to stratify our analyses by eth-
nicity to generate specific ethnicity-covariate estimates for risk of stroke onset due to having
small numbers of stroke patients per ethnic minority, particularly the Asian subgroup. Given
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the continuous population increase in Auckland and in New Zealand in general, it is likely that
we will have improved statistical power to investigate ethnicity-covariate interactions in a
future ARCOS study. Another limitation of our series of studies is that the first two ARCOS
studies (1981–1982 and 1991–1992) used a cluster sampling scheme approach for case-ascer-
tainment[97] and, therefore, may have underestimated the number of stroke cases in these
study periods. Although we applied the same criteria for cardiovascular risk factors recorded
across all studies, we acknowledge that the accuracy of information about these risk factors was
prone to some degree of variation and, therefore, should be interpreted with caution. However,
the consistency of the assessment procedures, diagnostic criteria, the implementation of quality
control procedures during the four studies, together with the decreased estimated number of
missing stroke cases (as determined by capture-recapture analyses), reassure us that case-ascer-
tainment was high across all these studies. Finally, due to the lack of reliable verification of
pathological types of stroke in the 1981–1982 and 1991–1992 studies, analysis of changes in
pathological types of stroke was limited to the 2002–2003 and 2011–2012 ARCOS studies. The
larger proportion of ischaemic strokes in 2011–2012 compared to 2002–2003 may be related to
a greater use of brain scanning (97% in 2011–2012; 88% in 2002–2003) which shifted classifica-
tion of some strokes as ‘undetermined’ to the ischaemic group.
Conclusions
A continuous and recently accelerated reduction in total stroke incidence and mortality has
been found over the last three decades in the Auckland region of NZ. Despite a trend towards
closing the gap in reducing the difference in stroke burden between NZ European and non-
European ethnic groups in NZ, the 15-year differences in the mean age of stroke onset in
Māori and Pacific compared to NZ/ Europeans has persisted. Some positive changes in the
profile of risk factors in people with stroke, such as overall decline in the proportion of current
smokers and recurrent strokes, and increased use of antiplatelet, blood pressure and lipid low-
ering medications, were counterbalanced by increasing prevalence of high blood pressure,
myocardial infarction, diabetes mellitus, AF, and low use of anticoagulants in people with AF.
This, together with the ongoing discordance between trends in stroke incidence and mortality
rates and persistent ethnic disparities in stroke burden, emphasises the need for better under-
standing of causes of ethnic disparities in stroke burden. Culturally appropriate primary stroke
prevention strategies need to be prioritised at a population level.[98] Some of these strategies
need government intervention in terms of increases in taxes on cigarettes and alcohol for
example, reduction in the levels of salt and sugar in the population,[99,100] the use of advertis-
ing campaigns informed by behavioural change methods to reduce smoking, alcohol, increase
physical activity, or evidence-based interventions. Government led health interventions should
include stroke programmes ideally already at the school age in the regular teaching plan
among other health education programs. To inform future stroke prevention strategies and
reduce stroke burden, a better understanding (including modelling)[101] of the interplay
between trends in stroke (and stroke sub-types) risk factors, demographic (e.g., aging of the
population, ethnic/racial disparities) and health care (e.g., introduction of acute stroke units,
thrombolysis for ischaemic stroke), morbidity (e.g. incidence and disability) and mortality rate
changes in different populations is required.
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